Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-13 08:57 am Sale | 2024-12-31 | 13G | Catalyst Pharmaceuticals, Inc. CPRX | Deerfield Mgmt, L.P. | 3,133,011 2.630% | -3,096,623 (-49.71%) | Filing History |
| 2024-11-14 09:55 am Sale | 2024-09-30 | 13G | Catalyst Pharmaceuticals, Inc. CPRX | Deerfield Mgmt, L.P. | 6,229,634 5.220% | -2,659,267 (-29.92%) | Filing History |
| 2024-11-08 5:31 pm Unchanged | 2024-09-30 | 13G | Catalyst Pharmaceuticals, Inc. CPRX | BlackRock Inc. BLK | 19,016,873 16.000% | 0 (Unchanged) | Filing History |
| 2024-10-18 3:31 pm Purchase | 2024-09-30 | 13G | Catalyst Pharmaceuticals, Inc. CPRX | BlackRock Inc. BLK | 19,016,873 16.000% | 3,195,472 (+20.20%) | Filing History |
| 2024-10-17 12:14 pm Sale | 2024-09-30 | 13G | Catalyst Pharmaceuticals, Inc. CPRX | STATE STREET CORP STT | 5,685,330 4.800% | -1,102,002 (-16.24%) | Filing History |
| 2024-02-13 5:00 pm Purchase | 2023-12-29 | 13G | Catalyst Pharmaceuticals, Inc. CPRX | VANGUARD GROUP INC | 7,120,417 6.680% | 351,676 (+5.20%) | Filing History |
| 2024-02-12 5:31 pm Purchase | 2023-12-31 | 13G | Catalyst Pharmaceuticals, Inc. CPRX | Deerfield Mgmt, L.P. | 8,888,901 8.340% | 3,004,453 (+51.06%) | Filing History |
| 2024-01-25 10:09 am Sale | 2023-12-31 | 13G | Catalyst Pharmaceuticals, Inc. CPRX | STATE STREET CORP STT | 6,787,332 6.370% | -1,085,982 (-13.79%) | Filing History |
| 2024-01-22 3:52 pm Purchase | 2023-12-31 | 13G | Catalyst Pharmaceuticals, Inc. CPRX | BlackRock Inc. BLK | 15,821,401 14.800% | 131,075 (+0.84%) | Filing History |
| 2023-02-14 12:27 pm Sale | 2022-12-31 | 13G | Catalyst Pharmaceuticals, Inc. CPRX | Armistice Capital, LLC | 0 0.000% | -9,572,000 (Position Closed) | Filing History |
| 2023-02-10 09:28 am Sale | 2022-12-31 | 13G | Catalyst Pharmaceuticals, Inc. CPRX | Deerfield Mgmt, L.P. | 5,884,448 5.650% | -176,043 (-2.90%) | Filing History |
| 2023-02-09 11:12 am Purchase | 2022-12-30 | 13G | Catalyst Pharmaceuticals, Inc. CPRX | VANGUARD GROUP INC | 6,768,741 6.500% | 1,932,428 (+39.96%) | Filing History |
| 2023-02-08 10:44 am Purchase | 2022-12-31 | 13G | Catalyst Pharmaceuticals, Inc. CPRX | STATE STREET CORP STT | 7,873,314 7.570% | 2,822,325 (+55.88%) | Filing History |
| 2023-01-26 08:52 am Unchanged | 2022-12-31 | 13G | Catalyst Pharmaceuticals, Inc. CPRX | BlackRock Inc. BLK | 15,690,326 15.100% | 0 (Unchanged) | Filing History |
| 2023-01-20 09:43 am Purchase | 2022-12-31 | 13G | Catalyst Pharmaceuticals, Inc. CPRX | BlackRock Inc. BLK | 15,690,326 15.100% | 421,395 (+2.76%) | Filing History |
| 2022-11-14 4:45 pm Purchase | 2022-11-04 | 13G | Catalyst Pharmaceuticals, Inc. CPRX | Deerfield Mgmt, L.P. | 6,060,491 5.820% | 6,060,491 (New Position) | Filing History |
| 2022-10-07 2:58 pm Purchase | 2022-09-30 | 13G | Catalyst Pharmaceuticals, Inc. CPRX | BlackRock Inc. BLK | 15,268,931 14.900% | 7,584,233 (+98.69%) | Filing History |
| 2022-02-14 6:28 pm Sale | 2021-12-31 | 13G | Catalyst Pharmaceuticals, Inc. CPRX | Armistice Capital, LLC | 9,572,000 9.300% | -428,000 (-4.28%) | Filing History |
| 2022-02-09 3:33 pm Sale | 2021-12-31 | 13G | Catalyst Pharmaceuticals, Inc. CPRX | VANGUARD GROUP INC | 4,836,313 4.690% | -934,766 (-16.20%) | Filing History |
| 2022-02-09 12:23 pm Sale | 2021-12-31 | 13G | Catalyst Pharmaceuticals, Inc. CPRX | STATE STREET CORP STT | 5,050,989 4.900% | -1,062,941 (-17.39%) | Filing History |